ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

13-valent pneumococcal vaccine

Also written as “13-valent pneumococcal conjugate vaccine”, “13-valent Pneumococcal Conjugate Vaccine” and “13vPnC”.

Its studies are mostly in Pneumococcal Infections · Pneumonia, Pneumococcal · Pneumonia · Influenza, Human · HIV Infections, led by 7 companies.

Drug page13-valent pneumococcal vaccine: every studyMany companies study it; this page follows only the 65 they lead. All 129 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Aug 27, 200865 company-led studies, 2 open or runningNext primary completion: Feb 15, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pfizer570 open or runningphase 4since Aug 27, 2008Sep 19, 2005none ahead
CanSino Biologicsits history only31 open or runningphase 3since Apr 8, 2021Sep 18, 2019Feb 15, 2027phase 3 · NCT07017777
Beijing Minhai Biotechnologyits history only10 open or runningphase 4since Jan 8, 2024Jan 8, 2024none ahead
Fosun Pharmaits history only11 open or runningphase 3since Feb 26, 2023Feb 26, 2023none ahead
Sinovac Biotechits history only10 open or runningphase 1since Oct 13, 2021Oct 13, 2021none ahead
Walvax Biotechnologyits history only10 open or runningphase 3since Mar 31, 2016Mar 31, 2016none ahead
Wuhan BravoVaxits history only10 open or runningphase 1since Oct 24, 2022Oct 24, 2022none ahead

Also a collaborator on its studies: Liaoning Chengda Biotechnology.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Pfizer only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 43 studies since Sep 19, 2005.

  1. Aug 12, 2011Phase 1 study in Pneumococcal InfectionsNCT01531322 · 72 enrolled · China
  2. May 10, 2012Phase 3 study in Pneumococcal VaccinesNCT01646398 · 764 enrolled · Japan
  3. Jul 11, 2012Phase 3 study in Pneumococcal InfectionsNCT01692886 · 1,674 enrolled · China
  4. Sep 9, 2013Phase 3 study in Pneumococcal VaccinesNCT01964716 · 500 enrolled · Gambia
  5. Jan 10, 2014Phase 4 study in Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnCNCT02034877 · 1,200 enrolled · India
  6. Apr 24, 2014Phase 4 study in Influenza, HumanNCT02124161 · 882 enrolled · United States
  7. May 22, 2018Phase 3 study in Pneumococcal InfectionsNCT03574389 · 936 enrolled · China
  8. May 22, 2018Phase 4 study in VaccinesNCT03548337 · 301 enrolled · India
  9. May 25, 2018Phase 2 study in Pneumococcal InfectionsNCT03550313 · 565 enrolled · United States
  10. Jun 20, 2018Phase 3 study in Pneumococcal InfectionsNCT03571607 · 206 enrolled · Japan
  11. Dec 4, 2018Phase 4 study in VaccinesNCT03777865 · 100 enrolled · India
  12. Mar 29, 2022No phase study in Immunogenicity, VaccineNCT05372575 · 300 enrolled · China
  13. Apr 7, 2022Phase 4 study in Pneumococcal InfectionsNCT05329259 · 200 enrolled · India
  14. Jun 5, 2025Phase 1 study in Pneumococcal InfectionsNCT07019909 · 400 enrolled · China

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“A pneumococcal conjugate vaccine containing 13 different strains of the bacterium Streptococcus pneumoniae, used in children and studied in immunocompromised patients for the prevention of pneumococcal disease”NCIt, by rule

Studies

All 57 Pfizer leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07019909Pneumococcal Infections · China1CompletedJan 28, 2026400
NCT05329259Pneumococcal Infections · India4CompletedNov 30, 2022200
NCT05372575Immunogenicity, Vaccine · China–CompletedDec 14, 2021300
NCT03777865Vaccines · India4CompletedApr 17, 2019100
NCT03571607Pneumococcal Infections · Japan3CompletedNov 16, 2018206
NCT03550313Pneumococcal Infections · United States2TerminatedNov 5, 2020565
NCT03574389Pneumococcal Infections · China3CompletedAug 23, 2021936
NCT03548337Vaccines · India4CompletedDec 20, 2019301
NCT02124161Influenza, Human · United States4CompletedMay 2015882
NCT02034877Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC · India4CompletedJul 20151,200
NCT01964716Pneumococcal Vaccines · Gambia3CompletedSep 2014500
NCT01692886Pneumococcal Infections · China3CompletedApr 20141,674
NCT01646398Pneumococcal Vaccines · Japan3CompletedOct 2012764
NCT01531322Pneumococcal Infections · China1CompletedJan 201272
NCT01392378Pneumococcal Vaccines · Poland4CompletedJan 2013908
NCT01432262Pneumococcal Infections · Mexico3CompletedDec 2011324
NCT01200368Healthy Subjects · Japan3CompletedNov 30, 2011551
NCT01193335Premature Birth · Poland, Spain4CompletedJan 2014200
NCT0102603813-valent Pneumococcal Vaccine · France3CompletedNov 2010263
NCT00980655Vaccines, Pneumococcal Conjugate Vaccine · United States, Belgium, Canada and more3CompletedMay 16, 2013251
NCT00963235HIV Infections · United States3CompletedMay 2012331
NCT00962780HIV Infections · Romania, South Africa3CompletedApr 2013303
NCT00918580Pneumococcal Conjugate Vaccine · United States, Egypt, France and more3CompletedMar 2013158
NCT00853749Invasive Pneumococcal Disease · Iceland3CompletedDec 16, 200989
NCT00824850Pneumococcal Conjugate Vaccine · United States2CompletedSep 201075
NCT00824655Pneumococcal Vaccines · Sweden3CompletedJun 2010234
NCT00761631Healthy Subjects · United States3CompletedAug 10, 20101,200
NCT00744263Pneumonia, Pneumococcal · Netherlands4CompletedOct 201384,496
NCT00743652Pneumococcal Infections · United States3CompletedSep 2010373
NCT00708682Vaccines, Pneumococcal · Mexico3CompletedMay 2010225
NCT00689351Disease · Korea, Republic of2CompletedDec 2009180
NCT00688870Vaccines · Taiwan3CompletedJan 13, 2010168
NCT00676091Vaccines, Pneumococcal Conjugate Vaccine · Brazil3CompletedSep 2009354
NCT00574795Vaccines, Pneumococcal Conjugate Vaccine · Japan3CompletedAug 2008193
NCT00574548Pneumococcal Vaccines · United States3CompletedFeb 2010720
NCT00562354Healthy · Japan3CompletedDec 2007271
NCT00546572Pneumococcal Infections · United States, Sweden3CompletedJul 2010938
NCT00521586Influenza, Human · United States3CompletedDec 20131,116
NCT00508742Pneumococcal Infections · Israel3CompletedAug 20111,866
NCT00500357Vaccines, Pneumococcal Conjugate Vaccine · South Africa3CompletedJan 2010105
NCT00500266Pneumococcal Infections · United States, Germany, Sweden3CompletedApr 20091,053
NCT00492557Pneumococcal Infections3CompletedFeb 20081,185
NCT00475033Vaccines, Pneumococcal Conjugate Vaccine · Canada3CompletedMay 2009603
NCT00474539Vaccines, Pneumococcal · Spain3CompletedMar 2009449
NCT00464945Pneumococcal Vaccines · Poland3CompletedSep 2008269
NCT00452790Pneumococcal Infections · India3CompletedOct 2009708
NCT00452452Pneumococcal Infections · Poland3CompletedMar 2008355
NCT00444457Vaccines, Pneumococcal · United States3CompletedJun 20091,712
NCT00427895Pneumococcal Infections · United States3CompletedAug 1, 20112,141
NCT00384059Vaccines, Pneumococcal · United Kingdom3CompletedOct 2008286
NCT00373958Vaccines, Pneumococcal · United States3CompletedJun 2008666
NCT00368966Vaccines, Pneumococcal · Spain3CompletedJul 2008619
NCT00366899Vaccines, Pneumococcal · Italy3CompletedJul 2008605
NCT00366678Vaccines, Pneumococcal · France3CompletedNov 2008613
NCT00366340Vaccines, Pneumococcal · Germany3CompletedAug 2008604
NCT00269672Vaccines, Pneumococcal Conjugate Vaccine2CompletedFeb 2007915
NCT00205803Pneumococcal Infections · United States2Completed249

How it is read

Names in the registry

  • “13-valent pneumococcal conjugate vaccine”, 23 entries
  • “13-valent Pneumococcal Conjugate Vaccine”, 20 entries
  • “13vPnC”, 9 entries
  • “13-valent pneumococcal conjugate vaccine (13vPnC)”, 8 entries
  • “PCV13”, 5 entries

Codes read as this program: PCV13I.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.